Join Pacific Biosciences’ Chief Scientific Officer, Jonas Korlach, as he discusses the scientific value of >10 kb, unbiased sequencing reads for an expanding range of applications. Single molecule, real-time (SMRT®) Sequencing technology has rapidly advanced in read lengths, throughput and adoption in the past year – we’ll review published work from a variety of researchers utilizing these new capabilities.
- Hear how SMRT Sequencing brings new insights to applications, such as: full-length transcript sequencing, de novo genome assembly, and targeted sequencing for minor-variant detection and haplotype phasing.
- Learn about recently published studies enabled by SMRT Sequencing in many different research areas.
- Find out how the current performance specifications for the PacBio® RS II system (read length, accuracy, uniformity and base-modification detection) can add a new dimension to your research
Who should attend:
Researchers who would like to learn more about the current capabilities and expanding applications of the PacBio RS II.
Presenter Biography
Jonas Korlach
Chief Scientific Officer, Pacific Biosciences
Dr. Korlach was appointed Chief Scientific Officer at Pacific Biosciences in July 2012. He was previously Scientific Fellow, supporting commercial development of the PacBio RS system and performing research aimed at developing new applications for Single Molecule, Real-Time (SMRT) technologies, such as base-modification detection. He co-invented the SMRT technology with Stephen Turner, Ph.D., Pacific Biosciences Founder and Chief Technology Officer, when the two were graduate students at Cornell University. He received both his Ph.D. and his M.S. degrees in Biochemistry, Molecular and Cell Biology from Cornell, and received M.S. and B.A. degrees in Biological Sciences from Humboldt University in Berlin, Germany.
Click on your preferred
time below to register:
Tuesday, April 29 5:00 p.m. PST
Wednesday, April 30 8:00 a.m. PST